SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShearwater Regulatory News (SWG)

Share Price Information for Shearwater (SWG)

Share Price is delayed by 15 minutes
Get Live Data
37.00    -0.50 (-1.33%)
Bid:
36.00
Ask:
38.00
Spread: 2.00 (5.556%)
Market Cap: £8.82m
SWG Live PriceLast checked at - London Stock Exchange

Intraday Shearwater Share Chart

Sch 1 - Shearwater Group Plc

1 Oct 2018 07:30

RNS Number : 4035C
AIM
01 October 2018
 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Shearwater Group plc

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

Registered office - 22 Great James Street, London, WC1N 3ES

Trading address - Octagon Point, 5 Cheapside, London EC2V 6AA

 

COUNTRY OF INCORPORATION:

England and Wales

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

https://www.theshearwatergroup.co.uk/

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

Shearwater is an AIM-quoted company focused on building a UK based group providing digital resilience solutions.

 

The Company's aim is to acquire and develop information security and cyber security companies with a leading product, solution or service capability whose full potential can be unlocked through active management and capital investment.

 

Shearwater Group plc is the holding company for the group's wholly-owned trading companies, including SecurEnvoy Limited, Xcina Limited and, following re-admission, Brookcourt Solutions Limited ("Brookcourt").

 

Brookcourt is a multi-award winning, UK-based cyber security company, focusing on the provision of networking and cyber security solutions to corporate and public sector organisations. Brookcourt's solutions help its customers by providing all and any aspect of the full end to end network design, supply, integration, support and managed services that a customer needs to assure and secure their network infrastructure in an advanced threat landscape. Brookcourt is headquartered in Redhill in Surrey, with a second office located in Bracknell and currently employs 28 people across both sites.

 

The Transaction consideration is £15.15m cash and £15.15m in Shearwater shares. This consideration structure has been amended from the earlier announced split of £22.95m cash and £7.35m in Shearwater shares. The cash consideration component of the Transaction will be financed through a fundraising consisting of a placing and an open offer (the "Fundraising"). The Transaction and the Fundraising are inter-conditional.

 

The Transaction constitutes a reverse takeover under AIM Rule 14 and accordingly, the Company will seek readmission ("Admission") of its shares to trading on AIM of the London Stock Exchange.

 

The Transaction and associated fundraising will be subject to the passing of relevant resolutions at the Company's general meeting to be confirmed.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

Up to 1,906,854,786 Ordinary shares of 1 penny each ("Ordinary Shares") (assuming full take up under the Open Offer).

 

There will be no Ordinary Shares held in treasury and no restrictions on the transfer of the securities.

 

CAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

Gross capital raised on admission - Placing of £16.7m and up to additional £1m under open offer.

 

Implied market capitalisation - £68.6m

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

Before Admission 45.8 per cent.

 

Post Admission 40.3 per cent.

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:

None

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

Directors

 

David Jeffreys Williams (Chairman)

 

Michael Joseph ("Mo") Stevens (Chief Executive Officer)

 

Robin Simon Southwell (Non-Executive Director)

 

Stephen Robert Ball (Non-Executive Director)

 

Giles Kirkley Willits (Non-Executive Director)

 

 

Proposed Directors

 

Paul John McFadden (Interim Finance Director)

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Significant Shareholder

30 June 2018

After Admission1

Phil Higgins

-

11.03%

Dene Stacy

-

11.03%

David Williams

12.04%

6.72%

Schroders

10.91%

8.61%

Stephen Watts

8.97%

4.68%

Andrew Kemshall

8.77%

4.58%

Killik & Co

5.48%

7.21%

Columbia Threadneedle

4.43%

3.19%

Canaccord Genuity WM

3.77%

3.42%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1. Assumes full take up of open offer.

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

N/A

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

(i) 31 March

(ii) Target's information is to 31 December 2017. Shearwater's information is audited annual financial information to 31 March 2018.

(iii) Half year report for the six months ended 30 September 2018 published by 31 December 2018. Annual report for the year ended 31 March 2019 published by 30 September 2019. Half year report for the six months ended 30 September 2019 published by 31 December 2019.

 

 

EXPECTED ADMISSION DATE:

17 October 2018

 

NAME AND ADDRESS OF NOMINATED ADVISER:

Cenkos Securities

6.7.8 Tokenhouse Yard

London EC2R 7AS

 

NAME AND ADDRESS OF BROKER:

Cenkos Securities

6.7.8 Tokenhouse Yard

London EC2R 7AS

 

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

The admission document containing full details about the Group and the admission of its ordinary shares will be available from the registered office of the Company, being 22 Great James Street, London WC1N 3ES, and on the Company's website www.theshearwatergroup.co.uk.

THE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY

QCA

 

DATE OF NOTIFICATION:

1 October 2018

 

NEW/ UPDATE:

New

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PAAUWAVRWUAKUAR
Date   Source Headline
18th May 20261:25 pmRNSAIM Rule 17 and Schedule 2(g)
29th Apr 20267:00 amRNSc.£1.8m contract win with major UK telco
1st Apr 20267:00 amRNSBoard Update
26th Mar 20265:17 pmRNSNotification of major holdings
17th Mar 20267:00 amRNSInterim Results
17th Mar 20267:00 amRNSInterim Results
12th Mar 20267:00 amRNS£1.3m contract win with major UK telco
3rd Mar 20267:00 amRNSNotice of Results and Investor Presentation
3rd Feb 20267:00 amRNSc.£9m Contract renewal and expansion
30th Jan 20261:12 pmRNSTotal Voting Rights
15th Jan 20267:00 amRNSBoard Update
23rd Dec 20257:00 amRNSContract Expansion
23rd Dec 20257:00 amRNSContract Expansion
16th Dec 202511:09 amRNSResult of AGM
10th Dec 20257:00 amRNSBlock Admission
4th Dec 20257:00 amRNS£7.3m Contract Extension
24th Nov 20257:00 amRNSNotice of AGM
18th Nov 202510:12 amRNSDirector share purchases
11th Nov 20257:00 amRNSResults for the 15-month period ended 30 June 2025
30th Oct 20257:00 amRNSNotice of Results and Presentation
21st Jul 20253:45 pmRNSIssue of New Shares to Shearwater Group Plc
11th Jul 20259:40 amRNSNotification of major holdings
10th Jul 202510:00 amRNSGrant of LTIP Options
9th Jul 20257:00 amRNSFY25 Trading Update
29th May 20254:17 pmRNSNotification of major holdings
28th May 20257:00 amRNS-RSWG company achieves landmark AI Certification
7th May 20257:00 amRNS£4.4m New Contract Win
2nd Apr 20257:00 amRNSContract Renewal
19th Feb 20253:56 pmRNSDirector dealing
17th Feb 20252:32 pmRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSUpdate re Spanish Gold Licences
30th Jan 20257:00 amRNSChange of Year End and Grant of LTIP options
20th Dec 20247:00 amRNS£2.3m Contract wins
26th Nov 20247:00 amRNSInterim Results
20th Nov 20247:00 amRNSNotice of Investor Presentation
7th Nov 20247:00 amRNSContract Wins and Notice of Results
25th Sep 20243:59 pmRNSBoard Update
29th Aug 20245:42 pmRNSNotice of AGM and Posting of Annual Report
27th Aug 20247:00 amRNSCFO Appointment
24th Jul 20247:00 amRNSResults for the year ended 31 March 2024
19th Jul 202412:43 pmRNSContract Win and Notice of Results
3rd Apr 20247:00 amRNSFY24 Trading Update
4th Jan 20247:00 amRNSContract Wins
22nd Nov 20237:00 amRNSInterim Results
21st Nov 202311:18 amRNSChange of Nominated Adviser and Broker
20th Nov 20231:19 pmRNSBoard Update
3rd Nov 202310:12 amRNSNotice of Results and Board Appointment
10th Oct 20237:00 amRNSInterim CFO Appointment
5th Sep 20237:00 amRNSFinal Results
25th Aug 20237:00 amRNSUpdate re FY23 Results and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.